TY  - JOUR
AU  - Pardal, Emilia
AU  - Diez-Baeza, Eva
AU  - Salas, Queralt
AU  - Garcia, Tomas
AU  - Sancho, Juan M
AU  - Monzon, Encarna
AU  - Moraleda, Jose M
AU  - Cordoba, Raul
AU  - de-la-Cruz, Fatima
AU  - Queizan, Jose A
AU  - Rodriguez, Maria J
AU  - Navarro, Belen
AU  - Hernandez, Jose A
AU  - Diez, Rosana
AU  - Vahi, Maria
AU  - Viguria, Maria C
AU  - Canales, Miguel
AU  - Peñarrubia, Maria J
AU  - Gonzalez-Lopez, Tomas J
AU  - Montes-Moreno, Santiago
AU  - Gonzalez-Barca, Eva
AU  - Caballero, Dolores
AU  - Martín, Alejandro
PY  - 2018
DO  - 10.1002/ajh.25107
UR  - http://hdl.handle.net/10668/12352
T2  - American journal of hematology
AB  - The means of optimally managing very elderly patients with diffuse large B-cell lymphoma (DLBCL) has not been established. We retrospectively analyzed 252 patients aged 80-100 years, diagnosed with DLBCL or grade 3B follicular lymphoma, treated in 19...
LA  - en
PB  - John Wiley & Sons, Inc.
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Prednisone
KW  - Rituximab
KW  - Spain
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Disease Management
KW  - Humans
KW  - Prognosis
KW  - Retrospective Studies
KW  - Survival Analysis
KW  - Vincristine
TI  - A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group.
TY  - research article
VL  - 93
ER  -